FLECTORMOVE 20 mg /G Гель

Содержание инструкции

1. FlectorMove 20 mg/g gel
   1. What is FlectorMove and what is it used for
   2. What you need to know before using FlectorMove
   3. How to use FlectorMove
   4. Possible side effects
   5. How to store FlectorMove
   6. Contents of the pack and other information

FlectorMove 20 mg/g gel

For adults and adolescents aged 14 years and over
Diclofenac, corresponding to diclofenac sodium (as diclofenac diethylamine)

Read this leaflet carefully before using this medicine as it contains important
information for you.
Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.

• Keep this leaflet. You may need to read it again.
• If you would like more information or advice, ask your pharmacist.
• If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
• Talk to your doctor if you do not feel better or if your symptoms worsen after 3-5 days.

Contents of this leaflet

• 1. What FlectorMove is and what it is used for
• 2. What you need to know before using FlectorMove
• 3. How to use FlectorMove
• 4. Possible side effects
• 5. How to store FlectorMove
• 6. Contents of the pack and other information

1. What is FlectorMove and what is it used for

FlectorMove contains the active ingredient diclofenac, which belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
FlectorMove is indicated
For adults and adolescents aged 14 years or older
For the symptomatic local treatment of pain associated with acute muscle strains, sprains or
contusions following impact trauma, for example injuries and sports accidents.
For adolescents aged 14 years or older, the medicine is indicated for short-term treatment.

2. What you need to know before using FlectorMove

Do not use FlectorMove

• if you are allergic to diclofenac or any of the other ingredients of this medicine (listed in section 6);
• if you have developed asthma attacks, urticaria, runny nose (acute rhinitis) after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs);
• on open wounds, inflammation or skin infections, on eczema or mucous membranes;
• if you are in the last three months of pregnancy (see “Pregnancy and breastfeeding”);
• in children and adolescents under 14 years of age.

Warnings and precautions
Consult your doctor or pharmacist before using FlectorMove.
If you suffer from asthma, allergic rhinitis, swelling of the nasal mucosa (so-called nasal polyps) or chronic obstructive bronchopneumonia, chronic respiratory infections (particularly associated with symptoms similar to allergic rhinitis), you are more likely than other patients to experience asthma attacks (so-called analgesic/asthma intolerance), local swelling of the skin or mucous membranes (so-called Quincke's edema) and urticaria.
In these patients, FlectorMove can only be used with certain precautions (preparation for emergencies) and under direct medical supervision. The same applies to patients who are also allergic to other substances and experience, for example, skin reactions, itching or urticaria.
When FlectorMove is applied to a large area of skin and for a prolonged period, the possibility of systemic adverse effects associated with the application cannot be excluded.
Apply FlectorMove only to intact, healthy skin without wounds. Avoid contact with eyes and oral mucous membranes. The gel should not be ingested.
After applying the gel to the skin, you can use a breathable (non-occlusive) bandage, but first allow the gel to dry on the skin for a few minutes. Do not use occlusive bandages that do not allow air to pass through.
Consult your doctor if symptoms worsen or do not improve within 3-5 days.
The use of FlectorMove should be discontinued if you develop a skin rash.
Avoid exposure to sunlight, including solariums, while using this medicine.
Take the necessary precautions to prevent children from touching the area to which the gel has been applied.

Children and adolescents
FlectorMove is contraindicated in children and adolescents under 14 years of age.

Other medicines and FlectorMove
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
To date, no interactions are known to be associated with the intended cutaneous use of FlectorMove.

Pregnancy, breastfeeding and fertility
If you are pregnant, suspect you are pregnant, are planning a pregnancy or are breastfeeding, ask your doctor or pharmacist for advice before using this medicine.
Pregnancy
Do not use FlectorMove if you are in the last 3 months of pregnancy. Do not use FlectorMove during the first 6 months of pregnancy unless strictly necessary and as directed by your doctor. If treatment is necessary during this period, the lowest dose should be used for the shortest possible time.
Oral forms (e.g. tablets) of diclofenac can cause adverse effects in the unborn child. It is not known whether the same risk applies with FlectorMove when used on the skin.
Breastfeeding
Diclofenac is secreted in small amounts in breast milk.
Consult your doctor before using FlectorMove during breastfeeding. In any case, if you are breastfeeding, do not apply FlectorMove directly to the breast or elsewhere on large areas of skin or for a prolonged period (see section 2 “Warnings and precautions”).

Driving and using machines
FlectorMove does not or negligibly alters the ability to drive vehicles or operate machinery.

FlectorMove contains propylene glycol (E1520), butylhydroxytoluene (E 321) and a fragrance with
limonene
This medicine contains 60 mg of propylene glycolper gram of gel.
This medicine contains butylhydroxytoluene (E 321)which may cause local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.
This medicine contains a fragrance with limonene, which may cause allergic reactions.

3. How to use FlectorMove

Use this medicine following exactly as described in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, ask your doctor or pharmacist.

Use in adults and adolescents aged 14 years and over
Depending on the size of the area to be treated, apply an amount of gel varying between a cherry and a walnut, corresponding to 1-4 g of gel.
FlectorMove should be applied twice a day (preferably in the morning and evening).
The maximum daily dose is 8 g of gel.

Use in elderly patients
No special dose adjustments are necessary. If you are elderly, you should pay particular attention to undesirable effects and, if necessary, consult your doctor or pharmacist.

Use in patients with hepatic or renal impairment
No dose reductions are necessary.

Use in children and adolescents under 14 years
FlectorMove is contraindicated in children and adolescents under 14 years of age (see section 2 “Do not use FlectorMove”).

Adolescents aged 14 years and over
If this medicine is needed for more than 7 days for pain treatment or if symptoms worsen, it is recommended that the patient/parents of the adolescent consult a doctor.

Route of administration
FlectorMove is for external use.
Apply a thin layer of FlectorMove to the affected parts of the body and gently massage into the skin. Afterwards, wipe your hands with a paper towel and then wash them, unless they are the area to be treated.
If an excessive amount of gel is accidentally applied, the excess gel should be wiped off with a paper towel.
The paper towel should be disposed of in household waste to prevent unused product from reaching the aquatic environment.
Before applying a bandage, allow the gel to dry on the skin for a few minutes. Also, wait for the gel to dry on the skin before showering or bathing.
How to remove the seal on first use:

• Unscrew and remove the cap of the tube.
• To remove the safety seal of the tube, use the back of the cap.

Duration of treatment
The duration of treatment depends on the indication and the patient’s response. FlectorMove should not be used for more than one to two weeks without consulting a doctor. If symptoms worsen or do not improve within 3-5 days, consult a doctor.

If you use more FlectorMove than you should
It is unlikely that an overdose will occur if you apply more FlectorMove than you should, since absorption into the bloodstream is poor when the medicine is used on the skin. If you apply a significantly higher dose to the skin than recommended, the gel should be removed (e.g. with a paper towel) and the area rinsed with water.
If you accidentally ingest FlectorMove, contact your doctor immediately or go to the nearest hospital emergency room. If you accidentally ingest the contents of a tube of FlectorMove, adverse effects similar to those observed after ingestion of an overdose of diclofenac for systemic use may occur.

If you forget to use FlectorMove
Do not use a double dose to make up for a missed dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may be serious. Stop using FlectorMove and seek medical advice immediately:

Rare side effects(may affect up to 1 in 1,000 people)

• Inflammation of the skin with blisters (bullous dermatitis)

Very rare side effects(may affect up to 1 in 10,000 people)

• Asthma
• Swelling of the face, lips, tongue or throat (angioedema)

Other side effects:
Common (may affect up to 1 in 10 people)

• Skin rash, redness of the skin (erythema), dermatitis (including contact dermatitis), itching.

Uncommon (may affect up to 1 in 100 people)

• Scaling, skin dehydration, edema.

Very rare (may affect up to 1 in 10,000 people)

• Rash with the appearance of pustules
• Gastrointestinal disorders
• Hypersensitivity reactions, including urticaria
• Sensitivity to light with the appearance of skin reactions following exposure to sunlight or sunlamps (photosensitivity reaction).

Frequency not known(the frequency cannot be estimated from the available data)

• Burning sensation at the application site.

When FlectorMove is applied to an extended area of skin and for a prolonged period, the possibility of systemic side effects (e.g., renal, hepatic or gastrointestinal side effects, systemic hypersensitivity reactions) similar to those that may occur after systemic administration of medicines containing diclofenac cannot be excluded.

Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly through the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse . By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store FlectorMove

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pack after “Exp.”. The expiry date refers to the last day of that month.
This medicine does not require any particular storage temperature.
Store the medicine in the original packaging to protect it from light.
Do not refrigerate or freeze.
After first opening, the gel can be used for a period of no more than 24 months, but not beyond the expiry date; after this period, any remaining gel must be disposed of.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Contents of the pack and other information

What FlectorMove contains

• The active ingredient is diclofenac. 1 g of gel contains 23.2 mg of diclofenac diethylamine, corresponding to 20 mg of diclofenac sodium.
• The other ingredients are: diethylamine, carbomer 974P, caprylic/capric triglyceride, macrogol cetostearyl ether, isopropyl alcohol, liquid paraffin, propylene glycol (E1520), eucalyptus essence (contains limonene), butylhydroxytoluene (E 321), oleyl alcohol, purified water.

Description of the appearance of FlectorMove and contents of the pack
FlectorMove is a homogeneous gel, from white to almost white.
Each pack contains a tube, sealed with a seal and a screw cap, containing 60 g, 100 g, 120 g and 150
g of gel.
Not all pack sizes may be marketed.

Marketing Authorisation Holder
IBSA Farmaceutici Italia S.r.l.
Via Martiri di Cefalonia 2,
26900 Lodi

Manufacturer
Doppel Farmaceutici S.r.l.
Via Martiri delle Foibe 1,
29016 Cortemaggiore (PC)

This medicinal product is authorised in the Member States of the European Economic Area with the following
names:
DE: Flector Schmerzgel
IT: FlectorMove